Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme

This phase II study aimed at determining the efficacy and safety of irinotecan combined with thalidomide in adults with recurrent glioblastoma multiforme (GBM) not taking enzyme-inducing anticonvulsants (EIACs). Adult patients (⩾18 years) with recurrent GBM with up to three relapses following surger...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Puduvalli, Vinay K., Giglio, Pierre, Groves, Morris D., Hess, Kenneth R., Gilbert, Mark R., Mahankali, Srikanth, Jackson, Edward F., Levin, Victor A., Conrad, Charles A., Hsu, Sigmund H., Colman, Howard, de Groot, John F., Ritterhouse, MeLesa G., Ictech, Sandra E., Alfred Yung, W. K.
Formato: Artigo
Lenguaje:Inglês
Publicado: Duke University Press 2008
Materias:
Clinical Investigations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2613824/
https://ncbi.nlm.nih.gov/pubmed/18314417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2007-060
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares